Successful booster antibody response up to 54 months after single primary vaccination with virosome-formulated, aluminum-free hepatitis A vaccine

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 37, Issue 9, 2003, Pages 126-128

  Beck, Bernhard R ^a   Hatz, Christoph ^a   Brönnimann, Rainer ^b   Herzog, Christian ^b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b Berna Biotech   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; HEPATITIS A VACCINE; VIROSOME VACCINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEPATITIS A; HUMAN; IMMUNIZATION; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; TRAVEL;

ADULT; AGED; ALUMINUM; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; TRAVEL; VACCINES, VIROSOME;

EID: 0642375764     PISSN: None     EISSN: 15376591     Source Type: Journal    
DOI: 10.1086/378890     Document Type: Article

References (0)